The Inflammatory Bowel Disease Clinical Decision Support Tool (IBD CDST) is a web-based tool providers can use to help predict a patient’s response to a biologic or targeted therapy before they even start it. A true point-of-care tool, the IBD CDST was developed and validated by leaders at the forefront of IBD and data science. In 2022, the IBD CDST was officially endorsed by the American Gastroenterology Association (AGA). Access this free tool anywhere in the world on all your devices and take advantage of what data science can do for your patients. Streamline your shared decision making, reduce guess work, and help your patients get better faster when you make your treatment decisions with the data-backed confidence the IBD CDST can provide for you and your patients.

Subscribe to RMEI now and get immediate access to use the IBD CDST indefinitely!